United States · Series C startup

Who invested in Biolinq

3 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$115Mraised across 3 rounds since 2017, from 3 sources

$10MSeries A$4.8MSeries A$100MSeries C
Latest round
Series C, $100MMar 2025
Step-upi
21.1×
Investors
10
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019202120232025
$10MSeries A$4.8MSeries A$100MSeries C
First round
Series A, $10M
Nov 2017
Biggest round
$100M
Series C · Mar 2025
Usual gap between rounds
5.9 years
the median of 2

The rounds

  1. Mar 2025
    Series C$100M2 new

    Source recordedSEC filing: $90M sold, first sale Mar 2025

  2. Mar 2019
    Series A$4.8M4 new1 returning

    Reported by FinSMEsSEC filing: $3.0M sold, first sale Mar 2019

  3. Nov 2017
    Series A$10M4 new

    Reported by FinSMEsSEC filing: $8.1M sold, first sale Nov 2017

Founders and team

From Biolinq's own website: 8 on the team.

  • Rich YangCEO
  • Amy VandenbergChief Regulatory & Clinical Officer
  • David RegoVP, Operations
  • Kate HunterVP, Regulatory Affairs
  • Chris DimitropoulosDirector
  • Daniel BradburyChairman of the Board
  • David BerryDirector
  • Thad JohnsonDirector

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2017Series A2019Series C2025LifeSci Venture PartnersPegasus Tech VenturesAlpha Wave GlobalAphelion CapitalM/VENTURESHikma VenturesT1D FundThree Leaf VenturesGrey SkyM Ventures/ Hikma

Everyone who backed them

LifeSci Venture PartnersVC firm2rounds
Pegasus Tech VenturesVC firm1round
Alpha Wave GlobalPrivate equity1round
Aphelion CapitalVC firm1round
M/VENTURESVC firm1round
Hikma VenturesCorporate VC1round
T1D FundCorporate VC1round
Three Leaf VenturesVC firm1round
Grey SkyVC firm1round
M Ventures/ Hikmano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 6 firms list Biolinq as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Nebraska Angel NetworkAngel networkPer its own site
Able PartnersVC firmPer its own site
Longevity VisionFamily officePer its own site
Endo InvestorsFamily officePer its own site
Features CapitalVC firmPer its own site
Standish Spring InvestmentsVC firmPer its own site

Quick answers about Biolinq

Who invested in Biolinq?

Biolinq's investors include LifeSci Venture Partners, Pegasus Tech Ventures, Alpha Wave Global, Aphelion Capital and M/VENTURES, and 5 more on record.

How much has Biolinq raised?

Biolinq has raised $115M across 3 rounds since 2017.

When did Biolinq last raise?

Biolinq's most recent round was a Series C of $100M in Mar 2025.

What was Biolinq's biggest round?

Its most recent round, $100M in Mar 2025, is also its largest on record.

Who backed Biolinq first?

Biolinq's first round on record, in Nov 2017, was backed by LifeSci Venture Partners, Three Leaf Ventures and Grey Sky and 1 others.

What stage is Biolinq at?

Biolinq's latest named round is a Series C, in Mar 2025.

Where is Biolinq based?

Biolinq is based in the United States.

Companies like Biolinq

In the same sector, and raised in the last eighteen months.

Star Therapeutics$325M · Oct 2026Promaxo$106M · Oct 2026Prolific Machines$105M · Oct 2026AI$18M · Oct 2026Baba$40M · Oct 2026IMIO$19M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app